ibogaine has been researched along with yohimbine in 2 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 5,893 | 253 | 532 |
| Protein | Taxonomy | ibogaine (IC50) | yohimbine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
| D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palumbo, PA; Winter, JC | 1 |
| Brandt, SD; Caspar, A; Maurer, HH; Meyer, MR | 1 |
2 other study(ies) available for ibogaine and yohimbine
| Article | Year |
|---|---|
Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
Topics: Animals; Conditioning, Operant; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Generalization, Stimulus; Ibogaine; Lysergic Acid Diethylamide; Male; Pizotyline; Rats; Rats, Inbred F344; Serotonin Antagonists; Stimulation, Chemical; Yohimbine | 1992 |
A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches.
Topics: Carbolines; Chromatography, Liquid; Designer Drugs; Humans; Ibogaine; Limit of Detection; Liquid-Liquid Extraction; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tryptamines; Yohimbine | 2014 |